Dr. Christopher M. Jewell serves as Chief Science Officer at Cartesian Therapeutics and holds professorships at the University of Maryland. He specializes in integrating engineering with immunology to develop disease-fighting therapies, reflecting his expertise in translational biomedical research and therapeutic innovation.

‌